ganaxalone – Patient Worthy

https://pixabay.com/en/books-stack-reading-read-education-933333/

Update: Phase 3 Data Published on Ganaxalone for CDD

Post author:Kendall Mason
Post published:April 21, 2022
Post category:CDKL5

According to a recent article in Businesswire, The Lancet has published data from the third phase of the Marigold trial. This clinical trial evaluated ganaxalone - marketed as ZTALMY - as a…

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More